Crossmark

Co-delivery of Liposomal Ketoconazole and Bevacizumab for Synergistical Inhibition of Angiogenesis Against Endometrial Cancer

Published Online: 2024-09-04

Published Print: 2025-07

Authors

Wang, Shanshan

Miao, Jinglin

Zhu, Ping

Xu, Li https://orcid.org/0009-0008-6196-6374
License Information

Text and Data Mining valid from 2024-09-04

Version of Record valid from 2024-09-04
More Information

Article History

Received: 8 September 2023

Accepted: 20 June 2024

First Online: 4 September 2024

Declarations

:

: All authors have declared no competing interests.

: This study was approved by the Yantai Yuhuangding Hospital.

Document is current